These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 105787)

  • 1. Therapeutic effect of topical antibiotic on untreated eye in experimental keratitis.
    Davis SD; Sarff LD; Hyndiuk RA
    Can J Ophthalmol; 1978 Oct; 13(4):273-6. PubMed ID: 105787
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Topical tobramycin therapy of experimental Pseudomonas keratitis: an evaluation of some factors that potentially enhance efficacy.
    Davis SD; Sarff LD; Hyndiuk RA
    Arch Ophthalmol; 1978 Jan; 96(1):123-5. PubMed ID: 414702
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bacteriologic cure of experimental Pseudomonas keratitis.
    Davis SD; Sarff LD; Hyndiuk RA
    Invest Ophthalmol Vis Sci; 1978 Sep; 17(9):916-8. PubMed ID: 100471
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Relative efficacy of the topical use of amikacin, gentamicin and tobramycin in experimental Pseudomonas keratitis.
    Davis SD; Sarff LD; Hyndiuk RA
    Can J Ophthalmol; 1980 Jan; 15(1):28-9. PubMed ID: 6769572
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A comparison of topical chlorhexidine, ciprofloxacin, and fortified tobramycin/cefazolin in rabbit models of Staphylococcus and Pseudomonas keratitis.
    Bu P; Riske PS; Zaya NE; Carey R; Bouchard CS
    J Ocul Pharmacol Ther; 2007 Jun; 23(3):213-20. PubMed ID: 17593004
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Iontophoresis of tobramycin for the treatment of experimental Pseudomonas keratitis in the rabbit.
    Rootman DS; Hobden JA; Jantzen JA; Gonzalez JR; O'Callaghan RJ; Hill JM
    Arch Ophthalmol; 1988 Feb; 106(2):262-5. PubMed ID: 3124801
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effectiveness of specific antibiotic/steroid combinations for therapy of experimental Pseudomonas aeruginosa keratitis.
    Engel LS; Callegan MC; Hobden JA; Reidy JJ; Hill JM; O'Callaghan RJ
    Curr Eye Res; 1995 Mar; 14(3):229-34. PubMed ID: 7796606
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antibiotic therapy of experimental Pseudomonas keratitis in guinea pigs.
    Davis SD; Sarff LD; Hyndiuk RA
    Arch Ophthalmol; 1977 Sep; 95(9):1638-43. PubMed ID: 197908
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treatment of experimental Pseudomonas keratitis using collagen shields containing tobramycin.
    Hobden JA; Reidy JJ; O'Callaghan RJ; Hill JM; Insler MS; Rootman DS
    Arch Ophthalmol; 1988 Nov; 106(11):1605-7. PubMed ID: 3142450
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Studies of tobramycin eye drops. Report 3. Therapeutic effect in experimental Peudomonas keratitis (author's transl)].
    Oishi M; Nishizuka K; Motoyama M; Ogawa T
    Nippon Ganka Gakkai Zasshi; 1977 Nov; 81(11):1783-6. PubMed ID: 613826
    [No Abstract]   [Full Text] [Related]  

  • 11. Tobramycin iontophoresis into corneas infected with drug-resistant Pseudomonas aeruginosa.
    Hobden JA; O'Callaghan RJ; Hill JM; Reidy JJ; Rootman DS; Thompson HW
    Curr Eye Res; 1989 Nov; 8(11):1163-9. PubMed ID: 2515036
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of minimal antibiotic treatment on bacterial keratitis.
    Hodges EJ; Friedlaender MH; Lee A; Okumoto M
    Cornea; 1989 Sep; 8(3):188-90. PubMed ID: 2501067
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effectiveness of a new tobramycin (0.3%) and dexamethasone (0.05%) formulation in the treatment of experimental Pseudomonas keratitis.
    McCormick C; Caballero A; Tang A; Balzli C; Song J; O'Callaghan R
    Curr Med Res Opin; 2008 Jun; 24(6):1569-75. PubMed ID: 18423106
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Corticosteroid in experimentally induced Pseudomonas keratitis: failure of prednisolone to impair the efficacy of tobramycin and carbenicillin therapy.
    Davis SD; Sarff LD; Hyndiuk RA
    Arch Ophthalmol; 1978 Jan; 96(1):126-8. PubMed ID: 414703
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A laboratory evaluation of antibiotic therapy for ciprofloxacin-resistant Pseudomonas aeruginosa.
    Rhee MK; Kowalski RP; Romanowski EG; Mah FS; Ritterband DC; Gordon YJ
    Am J Ophthalmol; 2004 Aug; 138(2):226-30. PubMed ID: 15289131
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Collagen shields containing tobramycin for sustained therapy (24 hours) of experimental Pseudomonas keratitis.
    Clinch TE; Hobden JA; Hill JM; O'Callaghan RJ; Engel LS; Kaufmann HE
    CLAO J; 1992 Oct; 18(4):245-7. PubMed ID: 1424060
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Topical ciprofloxacin versus topical fortified antibiotics in rabbit models of Staphylococcus and Pseudomonas keratitis.
    Lauffenburger MD; Cohen KL
    Cornea; 1993 Nov; 12(6):517-21. PubMed ID: 8261784
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy of tobramycin drops applied to collagen shields for experimental staphylococcal keratitis.
    Callegan MC; Engel LS; Clinch TE; Hill JM; Kaufman HE; O'Callaghan RJ
    Curr Eye Res; 1994 Dec; 13(12):875-8. PubMed ID: 7720394
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The efficacy of topical ciprofloxacin and norfloxacin in the treatment of experimental Pseudomonas keratitis.
    Reidy JJ; Hobden JA; Hill JM; Forman K; O'Callaghan RJ
    Cornea; 1991 Jan; 10(1):25-8. PubMed ID: 1902152
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparative study of the antibacterial activity of amikacin and tobramycin during Pseudomonas pulmonary infection in patients with cystic fibrosis.
    Levy J; Baran D; Klastersky J
    J Antimicrob Chemother; 1982 Sep; 10(3):227-34. PubMed ID: 6815155
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.